Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post hoc analyses of a randomized, double ‐blind, phase 3 study

ConclusionThese findings support once ‐weekly dulaglutide monotherapy as a treatment for Chinese patients with early stage type 2 diabetes.ClinicalTrials. gov: NCT01644500.This article is protected by copyright. All rights reserved.

Source: Journal of Diabetes Investigation - May 17, 2019 Category: Endocrinology Authors: Li Xin Shi, Xiao Min Liu, Yong Quan Shi, Quan Min Li, Jian Hua Ma, Yan Bing Li, Li Ying Du, Feng Wang, Lu Lu Chen Tags: Original Article Source Type: research